Zimmer Biomet
891 hedge funds and large institutions have $23.9B invested in Zimmer Biomet in 2018 Q3 according to their latest regulatory filings, with 83 funds opening new positions, 259 increasing their positions, 332 reducing their positions, and 51 closing their positions.
63% more first-time investments, than exits
New positions opened: 83 | Existing positions closed: 51
42% more funds holding in top 10
Funds holding in top 10: 12 → 17 (+5)
20% more capital invested
Capital invested by funds: $20B → $23.9B (+$3.94B)
3% more funds holding
Funds holding: 869 → 891 (+22)
0.97% more ownership
Funds ownership: 88.08% → 89.05% (+0.97%)
14% less call options, than puts
Call options by funds: $83.4M | Put options by funds: $97.1M
22% less repeat investments, than reductions
Existing positions increased: 259 | Existing positions reduced: 332
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$147M |
| 2 |
JP Morgan Chase
New York
|
+$127M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$82.1M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$74.2M |
| 5 |
O
OppenheimerFunds
New York
|
+$64.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
Longview Partners
St Peter Port,
Guernsey
|
-$144M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$71.9M |
| 3 |
Renaissance Technologies
New York
|
-$58.3M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
-$53.9M |
| 5 |
JP
Jana Partners
New York
|
-$50M |
ZBH Hedge Fund Activity: Q3 2018 in Review
891 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q3 2018, worth a combined $23.9B — up 20% from $20B a quarter earlier.
Buyers outnumbered sellers: 83 funds opened new ZBH positions and 51 closed out — a net gain of 32 holders — while 259 added to existing stakes and 332 trimmed.
The largest buyer was Millennium Management, adding an estimated $147M. The largest seller was Longview Partners, cutting an estimated $144M.
- 891 institutional investors held Zimmer Biomet (ZBH) as of Q3 2018, up from 869 in Q2 2018.
- Funds reported $23.9B of Zimmer Biomet stock for Q3 2018, up 20% quarter-over-quarter.
- 83 funds opened new Zimmer Biomet positions in Q3 2018 and 51 closed out, a net change of +32 holders.
- The largest Zimmer Biomet buyer in Q3 2018 was Millennium Management, an estimated $147M added.
- The largest Zimmer Biomet seller in Q3 2018 was Longview Partners, an estimated $144M sold.
Based on aggregated 13F filings for Q3 2018.